SCHEMBL19611546

SCHEMBL19611546

N/C(Cc1ccc(Cl)c(Cl)c1)=N\O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.50
POLB P06746 1/20 0.50
LMNA P02545 2/20 0.49
KMT2A Q03164 2/20 0.49
TAAR1 Q96RJ0 2/20 0.49
GAA P10253 1/20 0.48
CRHBP P24387 1/20 0.48
CRHR2 Q13324 1/20 0.48
IDO1 P14902 5/20 0.47
PNMT P11086 2/20 0.47
PIK3CA P42336 1/20 0.42
HSD17B10 Q99714 1/20 0.41
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
IGF1R P08069 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836981 1.00 HSP90AA1 (0.50) HSP90AA1POLBLMNAKMT2ATAAR1
SCHEMBL22615041 1.00 HSP90AA1 (0.50) HSP90AA1POLBLMNAKMT2ATAAR1
Hydrochloric Acid SCHEMBL11553545 0.98 HSP90AA1 (0.49) HSP90AA1POLBLMNAKMT2ATAAR1
SCHEMBL13012444 0.84 HSD17B10 (0.39) HSP90AA1POLBLMNAKMT2ATAAR1
SCHEMBL2130637 0.84 HSP90AA1 (0.44) HSP90AA1POLBLMNAKMT2ATAAR1
SCHEMBL2130632 0.84 HSP90AA1 (0.44) HSP90AA1POLBLMNAKMT2ATAAR1
SCHEMBL18703985 0.81 TAAR1 (0.53) TAAR1IDO1PNMTIGF1RALOX15
SCHEMBL18703983 0.81 TAAR1 (0.53) TAAR1IDO1PNMTIGF1RALOX15
SCHEMBL9314304 0.81 TAAR1 (0.63) HSP90AA1POLBLMNAKMT2ATAAR1
SCHEMBL14827527 0.78 CTBP2 (0.53) HSP90AA1LMNAKMT2ATAAR1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215505-B1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE Bayer Pharma AG (DE) 2019-07-24 EP disclosed
US-10118930-B2 Piperidinylpyrazolopyrimidinones and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-11-06 US disclosed
US-20170334917-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10118930-B2 Piperidinylpyrazolopyrimidinones and their use HAMP, SERPINC1, PRSS8 HSP90AA1 58/4885POLB 3149/4885LMNA 2585/4885
US-20170334917-A1 PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE HAMP, SERPINC1, PRSS8 HSP90AA1 58/4885POLB 3149/4885LMNA 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.